• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Sy Mukherjee

Sy Mukherjee is a former health care reporter for Fortune.

COVID forgotten communities
NewslettersThe communities we forget during COVID-19
By Sy MukherjeeApril 30, 2020
Gilead remdesivir coronavirus FDA
HealthGilead’s remdesivir won’t be a COVID-19 miracle cure, but it’s still an important first step
By Sy MukherjeeApril 30, 2020
The coronavirus pandemic is impacting critical research into neuromuscular diseases
HealthThe coronavirus pandemic is impacting critical research into neuromuscular diseases
By Sy MukherjeeApril 28, 2020
Coronavirus treatment approach
NewslettersThe 3-pronged approach to defeating the coronavirus
By Sy MukherjeeApril 23, 2020
Elective surgeries—mostly paused due to the pandemic—are critical to hospital finances
HealthElective surgeries—mostly paused due to the pandemic—are critical to hospital finances
By Sy MukherjeeApril 23, 2020
Big Pharma has the chance to come to the world’s rescue
MagazineBig Pharma has the chance to come to the world’s rescue
By Sy MukherjeeApril 20, 2020
Coronavirus tests and their discontents
NewslettersCoronavirus tests and their discontents
By Sy MukherjeeApril 16, 2020
Coronavirus Drive Thru Testing Penn State Health Saint Joseph
HealthThere are 32 authorized coronavirus tests so far—here’s how they differ
By Sy MukherjeeApril 10, 2020
The key problem to solve in the quest for coronavirus treatments
NewslettersThe key problem to solve in the quest for coronavirus treatments
By Sy MukherjeeApril 9, 2020
Joe Biden’s health care plan for the coronavirus and beyond
HealthJoe Biden’s health care plan for the coronavirus and beyond
By Sy MukherjeeApril 3, 2020
Coronavirus earth
NewslettersCoronavirus is (literally) shaking up how the world moves
By Sy MukherjeeApril 2, 2020
J&J coronavirus
NewslettersJ&J’s coronavirus vaccine could hit the market by 2021
By Sy MukherjeeMarch 30, 2020
Johnson & Johnson hopes to have its promising coronavirus vaccine approved by early 2021
HealthJohnson & Johnson hopes to have its promising coronavirus vaccine approved by early 2021
By Sy MukherjeeMarch 30, 2020
Coronavirus cases U.S.
NewslettersThe U.S. now has the most coronavirus cases in the world
By Sy MukherjeeMarch 27, 2020
Henry Schein says its coronavirus test takes just 15 minutes, and there’s no swab necessary
NewslettersHenry Schein says its coronavirus test takes just 15 minutes, and there’s no swab necessary
By Sy MukherjeeMarch 26, 2020
1...
  • 16
  • 17
  • 18
  • 19
  • 20
...100
Most Popular
Personal Finance
Social Security's 2032 deadline puts a 22% cut on the table — but Washington has way less room to negotiate than 1983placeholder alt text
By John W. Diamond and The ConversationJune 12, 2026
Success
CEO of $20 billion AI firm Perplexity says the secret to success is ‘sleeping with that fear’ that your competitor will steal your ideaplaceholder alt text
By Preston ForeJune 13, 2026
Economy
Boomers actually do hold most of the wealth and power. So why do they call it 'whiny' to point that out?placeholder alt text
By Nick LichtenbergJune 14, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.